Humoral leukocyte adherence inhibition response in patients with oral cancer.
Antitumor immunity was assessed in a group of 10 patients suffering from squamous cell carcinoma of the oral cavity using the humoral leukocyte adherence inhibition assay (H-LAI). A tumor extract from a person with cancer of the tongue was used as antigen. Sera from five patients with carcinoma of the tongue were all positive in the test. Of the other five patients, three had cancer of the lips while in two patients the type was unspecified. All patients except one with cancer of the lips gave a positive response in the test. Thus, of the 10 patients with carcinoma of the oral cavity, nine responded. Among nine controls, one person gave a positive response.
Becher
R
R
Laboratory for Environmental and Occupational Cancer, Norwegian Radium Hospital, Oslo.
Kotlar
H K
HK
Sanner
T
T
D000951:Antigens, Neoplasm / Q000276:immunology*; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000276:immunology*; D006801:Humans; D007957:Leukocyte Adherence Inhibition Test; D007962:Leukocytes / Q000276:immunology*; D009062:Mouth Neoplasms / Q000097:blood / Q000276:immunology*; D014062:Tongue Neoplasms / Q000276:immunology
D000951:Antigens, Neoplasm